
Linda A. DiMeglio, MD
Pediatric Endocrinology & Diabetology
Employed Provider
Accepting New Patients
On This Page
About Me
Dr. Linda A. DiMeglio specializes in Pediatric Endocrinology for Riley Pediatric Diabetes & Endocrinology. Dr. DiMeglio earned her medical degree at the University of Pennsylvania. She then completed internships at Northwestern University Feinberg School of Medicine and Children's Memorial Hospital residencies at Northwestern University Feinberg School of Medicine and Children's Memorial Hospital, and a fellowship at Indiana University School of Medicine.
Dr. DiMeglio's primary location is Riley Pediatric Diabetes & Endocrinology, 575 Riley Hospital Dr, Indianapolis, IN 46202. She also sees patients at offices in South Bend and Fort Wayne. In addition to English, she speaks Spanish.
Locations

575 Riley Hospital Dr
MSA3
Indianapolis, IN, 46202
Get Directions 317.944.3889
211 N Eddy St
1st Floor
South Bend, IN, 46617
Get Directions 317.944.3889
1801 N. Senate Blvd.
Suite 402
Indianapolis, IN, 46202
Get Directions 317.944.3889
415 E Cook Rd
Suite 300
Fort Wayne, IN, 46825
Get Directions 260.234.5300Specialties & Details
- Pediatric Endocrinology & Diabetology
- School of Medicine: University of Pennsylvania
- Internship: Northwestern University Feinberg School of Medicine, Chicago, IL
- Internship: Children's Memorial Hospital, Chicago, IL
- Residency: Northwestern University Feinberg School of Medicine, Chicago, IL
- Residency: Children's Memorial Hospital, Chicago, IL
- Fellowship: Indiana University School of Medicine, Indianapolis, IN
- IU Health Methodist Hospital
- Riley Physicians
- IU Health Medical Group
Insurance Accepted
Note: Although this listing was accurate at the time of posting, insurances change regularly, and insurance plans listed may not be accepted at all office locations for this provider. Please confirm with your insurance company that this provider is covered by your plan before your appointment.
Clinical Trials
Explore the ongoing clinical trials this provider is involved in and learn about the eligibility requirements for each one. Search the clinical trial directory to find additional clinical trials.
Open-label, single-arm, multiple-dose safety, titration, and pharmacokinetic study of AFREZZA® in pediatric subjects ages 4 to 17 years with type 1 diabetes mellitus
View DetailsDESIGNATE: A T cell phenotype signature driven dose finding study with siplizumab in type 1 diabetes mellitus
View DetailsTrialNet Pathway to Prevention of T1D
View DetailsRelated Stories

Jack, Jonathin and Goshi are just two of the hundreds of kids with physical and cognitive differences who flourished at Camp Riley last year. Applications are now being accepted for this summer’s sessions.
Read the Story
Division chief of pediatric diabetology and endocrinology at Riley Children's Health is renowned for compelling contributions to pediatric healthcare.
Read the Story
A new drug approved by the FDA last year delays the onset of stage 3 type 1 diabetes.
Read the Story